These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 17484755)

  • 1. Epilepsy in phenylketonuria: a complex dependence on serum phenylalanine levels.
    Martynyuk AE; Ucar DA; Yang DD; Norman WM; Carney PR; Dennis DM; Laipis PJ
    Epilepsia; 2007 Jun; 48(6):1143-50. PubMed ID: 17484755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future role of large neutral amino acids in transport of phenylalanine into the brain.
    Matalon R; Surendran S; Matalon KM; Tyring S; Quast M; Jinga W; Ezell E; Szucs S
    Pediatrics; 2003 Dec; 112(6 Pt 2):1570-4. PubMed ID: 14654667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma phenylalanine concentrations are associated with hepatic iron content in a murine model for phenylketonuria.
    Gropper SS; Yannicelli S; White BD; Medeiros DM
    Mol Genet Metab; 2004 May; 82(1):76-82. PubMed ID: 15110326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylalanine ammonia lyase, enzyme substitution therapy for phenylketonuria, where are we now?
    Sarkissian CN; Gámez A
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S22-6. PubMed ID: 16165390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome.
    Güttler F; Azen C; Guldberg P; Romstad A; Hanley WB; Levy HL; Matalon R; Rouse BM; Trefz F; de la Cruz F; Koch R
    Pediatrics; 2003 Dec; 112(6 Pt 2):1530-3. PubMed ID: 14654659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Audiogenic seizure susceptibility is reduced in fragile X knockout mice after introduction of FMR1 transgenes.
    Musumeci SA; Calabrese G; Bonaccorso CM; D'Antoni S; Brouwer JR; Bakker CE; Elia M; Ferri R; Nelson DL; Oostra BA; Catania MV
    Exp Neurol; 2007 Jan; 203(1):233-40. PubMed ID: 17007840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice.
    Mochizuki S; Mizukami H; Ogura T; Kure S; Ichinohe A; Kojima K; Matsubara Y; Kobayahi E; Okada T; Hoshika A; Ozawa K; Kume A
    Gene Ther; 2004 Jul; 11(13):1081-6. PubMed ID: 15057263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
    Trefz FK; Blau N
    Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained attention in adult phenylketonuria: the influence of the concurrent phenylalanine-blood-level.
    Schmidt E; Rupp A; Burgard P; Pietz J; Weglage J; de Sonneville L
    J Clin Exp Neuropsychol; 1994 Oct; 16(5):681-8. PubMed ID: 7836491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
    Diamond A; Prevor MB; Callender G; Druin DP
    Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low total antioxidant status is implicated with high 8-hydroxy-2-deoxyguanosine serum concentrations in phenylketonuria.
    Schulpis KH; Tsakiris S; Traeger-Synodinos J; Papassotiriou I
    Clin Biochem; 2005 Mar; 38(3):239-42. PubMed ID: 15708545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental models of multifactorial epilepsies: the EL mouse and mice susceptible to audiogenic seizures.
    Seyfried TN; Todorova MT; Poderycki MJ
    Adv Neurol; 1999; 79():279-90. PubMed ID: 10514820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets.
    Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I
    Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
    Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term changes in glutamatergic synaptic transmission in phenylketonuria.
    Glushakov AV; Glushakova O; Varshney M; Bajpai LK; Sumners C; Laipis PJ; Embury JE; Baker SP; Otero DH; Dennis DM; Seubert CN; Martynyuk AE
    Brain; 2005 Feb; 128(Pt 2):300-7. PubMed ID: 15634735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of prepotent responding and attentional flexibility in treated phenylketonuria.
    Huijbregts S; de Sonneville L; Licht R; Sergeant J; van Spronsen F
    Dev Neuropsychol; 2002; 22(2):481-99. PubMed ID: 12537335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term dietary intervention with low Phe and/or a specific nutrient combination improve certain aspects of brain functioning in phenylketonuria (PKU).
    Bruinenberg VM; van Vliet D; van der Goot E; Counotte DS; Kuhn M; van Spronsen FJ; van der Zee EA
    PLoS One; 2019; 14(3):e0213391. PubMed ID: 30875376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of urinary tryptophan metabolites in relation to the phenylalanine content of semi-synthetic diets in a patient with phenylketonuria.
    Byrd DJ; Kochen W; Schürrle L; Trefz FK
    Acta Vitaminol Enzymol; 1975; 29(1-6):55-61. PubMed ID: 1244125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
    Sawin EA; Murali SG; Ney DM
    Mol Genet Metab; 2014 Apr; 111(4):452-61. PubMed ID: 24560888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice.
    De Luca G; Di Giorgio RM; Macaione S; Calpona PR; Costantino S; Di Paola ED; De Sarro A; Ciliberto G; De Sarro G
    Pharmacol Biochem Behav; 2004 May; 78(1):75-81. PubMed ID: 15159136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.